Skip to main content
Daily Report

Daily Cosmetic Research Analysis

07/11/2026
3 papers selected
19 analyzed

Analyzed 19 papers and selected 3 impactful papers.

Summary

A single-center randomized trial shows CAD-CAM splints improve short-term occlusal outcomes over conventional arch bars in dentate mandibular fractures. A PROSPERO-registered meta-analysis of nine RCTs finds that pre-emptive corticosteroid injections significantly reduce post-endodontic pain, especially within 12 hours. A scoping review of 307 studies reveals selective reporting of BREAST-Q domains, urging comprehensive, standardized PROM reporting in reconstructive and cosmetic breast surgery.

Research Themes

  • Digital planning (CAD-CAM) to enhance surgical outcomes
  • Peri-procedural corticosteroid strategies for pain reduction
  • Standardization and bias reduction in PROM reporting (BREAST-Q)

Selected Articles

1. CAD-CAM Splints Versus Arch Bars for Management of Dentate Mandibular Fractures - A Randomized Control Study.

65Level IIRCT
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2026PMID: 42431600

In a single-center, single-blind RCT of 32 dentate mandibular fracture patients undergoing ORIF, CAD-CAM splints achieved 100% normal occlusion at 4 weeks versus 75% with arch bars (P=.02). While mean operative and preparation times were not statistically different overall, CAD-CAM reduced postoperative MMF needs in complex patterns and may shorten operative time in selected subgroups.

Impact: Provides randomized evidence that digital CAD-CAM splints can improve short-term occlusal outcomes over conventional arch bars, informing maxillofacial trauma practice.

Clinical Implications: Consider CAD-CAM splints as a preferred MMF option—particularly for complex patterns—to enhance early occlusal outcomes and potentially reduce postoperative MMF requirements.

Key Findings

  • Normal occlusion at 4 weeks: 100% with CAD-CAM vs 75% with arch bars (P=0.02).
  • Overall mean operative and preparation times showed no statistically significant differences.
  • CAD-CAM splints were associated with reduced postoperative MMF needs in complex fracture patterns and shorter operative time in selected subgroups.

Methodological Strengths

  • Randomized, single-blind design with clearly defined outcomes.
  • Direct head-to-head comparison of MMF techniques in a homogeneous clinical indication.

Limitations

  • Small, single-center trial limits generalizability.
  • Not powered for all secondary endpoints; blinding limited and preparation time trends may favor arch bars.

Future Directions: Multicenter RCTs powered for secondary endpoints, cost-effectiveness analyses, and objective occlusal metrics to refine CAD-CAM adoption criteria.

BACKGROUND: Mandibular fractures are technically demanding because accurate restoration of occlusion is required and conventional maxillomandibular fixation (MMF) techniques have important limitations. PURPOSE: The purpose of this study was to measure and compare the clinical efficacy of CAD-CAM splints versus conventional arch bars as MMF techniques in subjects undergoing open reduction and internal fixation (ORIF) of mandibular fractures in the dentate region. STUDY DESIGN AND SETTING: This single-blind randomized clinical study was conducted in the Department of Oral and Maxillofacial Surgery at a tertiary academic center between September 2022 and March 2024. Adult patients indicated for ORIF of mandibular fractures in the dentate region were eligible. Exclusion criteria were isolated condylar fractures, comminuted or edentulous mandibular fractures, and associated midface fractures affecting occlusion. PREDICTOR VARIABLE: The primary predictor variable was the MMF technique and subjects were randomly assigned to CAD-CAM splint or conventional arch bar groups. OUTCOME VARIABLES: The primary outcome was clinical efficacy, assessed by postoperative occlusion, need for and duration of postoperative MMF, and operative time. Secondary outcomes included lower border step deformity, lingual cortical reduction, preparation time, and achievement of condylar pushback. COVARIATES: The covariates were demographics, fracture patterns, and presence of associated condylar fractures and their management. STATISTICAL ANALYSIS: Appropriate tests were used for analysis with significance set at P < .05. RESULTS: The sample was composed of 32 subjects (16 in each group) with a mean age of 29.9 years (standard deviation [SD] 10.7); 28 (87.5%) were males. Normal occlusion at 4 weeks was achieved in 16 of 16 (100%) CAD-CAM subjects and 12 of 16 (75%) arch bar subjects (P = .02). The combined mean operative time was 50.4 minutes (SD 15.8) for CAD-CAM and 59.9 minutes (SD 18.1) for arch bars (P = .1). The combined mean preparation time was 90.9 minutes (SD 9.4) for CAD-CAM splints and 83.9 minutes (SD 10.5) for arch bars (P = .1). CONCLUSION AND RELEVANCE: CAD-CAM splints as an MMF technique are associated with improved occlusal outcomes, a lower need for postoperative MMF in complex fracture patterns, and shorter operative times in selected subgroups compared with conventional arch bars.

2. Effect of Pre-emptive Injection-based Corticosteroid Administration and Its Routes on Post-Endodontic Pain: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

64.5Level IMeta-analysis
Journal of clinical and experimental dentistry · 2026PMID: 42434206

Across nine RCTs (n=917), pre-emptive corticosteroid injections—most commonly dexamethasone—significantly reduced post-endodontic pain at all evaluated time points, with the largest effect within 12 hours and sustained benefit up to 72 hours. Infiltrative injections outperformed intraligamentary routes.

Impact: This PROSPERO-registered, PRISMA-compliant meta-analysis consolidates RCT evidence clarifying both efficacy and preferred routes for corticosteroid injections to mitigate post-endodontic pain.

Clinical Implications: Consider pre-emptive dexamethasone via infiltrative injection before root canal treatment to reduce early postoperative pain, with effects extending up to 72 hours.

Key Findings

  • Nine RCTs (n=917) showed significant reductions in post-endodontic pain versus placebo at all time points.
  • Greatest analgesic effect occurred within the first 12 hours, with benefits persisting up to 72 hours.
  • Infiltrative injections demonstrated greater efficacy than intraligamentary routes; dexamethasone was prominently effective.

Methodological Strengths

  • PRISMA 2020 compliant with PROSPERO preregistration.
  • Risk of bias assessed using Cochrane RoB 2.0; multi-database search; RCT-only inclusion.

Limitations

  • Clinical and methodological heterogeneity (drug type, dose, route, pain scales) limited subgroup precision.
  • Limited data beyond 72 hours and variable timing of pain assessments across trials.

Future Directions: Head-to-head RCTs comparing specific steroids and standardized dosing/route protocols with longer follow-up to define optimal regimens and safety.

BACKGROUND: Post-endodontic pain PP is a frequent complication following root canal treatment RCT, primarily resulting from acute inflammation. Pre-emptive corticosteroid administration has been proposed to attenuate this inflammatory response and reduce PP. This systematic review and meta-analysis assessed the effectiveness of injection-based corticosteroids delivered through different routes in minimizing PP at various postoperative intervals. MATERIAL AND METHODS: A comprehensive search of PubMed, Scopus, Web of Science, LILACS, Cochrane Library, and Google Scholar was conducted up to March 2025, following PRISMA 2020 guidelines. Randomized controlled trials evaluating pre-emptive corticosteroid injections via infiltrative, intraligamentary, or intramuscular routes were included. Risk of bias was assessed using the Cochrane RoB 2.0 tool, and meta-analyses were performed using Review Manager 5.4. The review was prospectively registered in PROSPERO CRD420251005886. RESULTS: Nine RCTs comprising 917 participants were analyzed. Corticosteroid injections, including dexamethasone, methylprednisolone, and betamethasone, significantly reduced PP compared with placebo at all time points, with the most pronounced effect within the first 12 hours and sustained, though reduced, benefits up to 72 hours. Infiltrative injections demonstrated greater efficacy than intraligamentary routes. CONCLUSIONS: Pre-emptive corticosteroid injections, particularly dexamethasone via infiltrative or intraligamentary routes, effectively reduce post-endodontic pain, especially within the first 24 hours.

3. BREAST-Q Under the Microscope: A Scoping Review of Reporting Gaps in Breast Surgery.

54Level IISystematic Review
Aesthetic surgery journal. Open forum · 2026PMID: 42434378

A scoping review of 307 studies found that BREAST-Q reporting is inconsistent, with selective emphasis on psychosocial well-being, satisfaction with breasts, and sexual well-being. Cosmetic cohorts had higher aggregate weighted means than reconstruction cohorts (81.99 vs 74.49), but analyses were descriptive due to heterogeneity; comprehensive domain reporting or an overall summary score is recommended.

Impact: By exposing systematic reporting gaps in a widely used PROM, this review provides a roadmap for standardizing outcome reporting in reconstructive and cosmetic breast surgery.

Clinical Implications: Adopt comprehensive, domain-wide BREAST-Q reporting or include an overall summary score to reduce bias and enable meaningful cross-study comparisons and benchmarking.

Key Findings

  • Systematic search identified 307 eligible studies from 6921 records across 5 databases.
  • Most frequently reported domains: psychosocial well-being, satisfaction with breasts, and sexual well-being (Reconstruction: 79.12%, 91.21%, 77.29%; Cosmetic: 74.55%, 96.36%, 83.64%).
  • Aggregate weighted mean BREAST-Q scores were higher in cosmetic versus reconstruction groups (81.99 vs 74.49), but estimates were descriptive and not direct comparisons.
  • Selective domain reporting introduces bias and limits comparability; comprehensive reporting or an overall summary score is advised.

Methodological Strengths

  • Comprehensive multi-database search with explicit inclusion criteria across cosmetic and reconstruction cohorts.
  • Large body of literature enabling domain coverage analysis and weighted aggregation.

Limitations

  • Descriptive analyses only due to heterogeneity; no meta-analysis or adjusted comparisons.
  • Potential publication and selective reporting biases inherent to included studies.

Future Directions: Develop consensus reporting standards for BREAST-Q (domain completeness or validated summary indices) and encourage prospective registration of PROM endpoints.

The BREAST-Q was developed to address a gap in breast surgery outcomes research as a validated, procedure-specific patient-reported outcome measure (PROM) that assesses satisfaction and health related quality of life. Despite global adoption, reporting practices remain inconsistent. This review evaluated how BREAST-Q domains are reported and compated outcomes between postmastectomy reconstruction and cosmetic breast surgery populations. Five databases (PubMed, MEDLINE, PsycINFO, Scopus, and Web of Science) were searched from January 1, 2009 to September 16, 2022. Of 6921 records, 307 studies met inclusion criteria. Eligible studies reported mean BREAST-Q scores (0-100 scale) in patients undergoing postmastectomy reconstruction, breast augmentation, or breast reduction. Studies were grouped as reconstruction (Group 1) or cosmetic (Group 2). Extracted data included publication year, country, sample size, BREAST-Q means ± standard deviation and domain coverage. Analyses were descriptive due to heterogeneity in design, populations, and follow-up The most frequently reported domains in both groups were psychosocial well-being, satisfaction with breasts, and sexual well-being (Group 1: 79.12%, 91.21%, and 77.29%; Group 2: 74.55%, 96.36%, and 83.64%). The aggregate global weighted mean BREAST-Q score was higher in Group 2 than in Group 1 (81.99 vs 74.49), Though these values represent descriptive estimates, not direct comparisons. Although widely used, BREAST-Q reporting is inconsistent, with disproportionate emphasis on select domains. This selective reporting introduces bias and limits comparability. Comprehensive reporting across all domains, or inclusion of an overall summary score, would better reflect patient satisfaction and align with the instrument's intended purpose. Level of Evidence: 3 (Therapeutic).